Abbott Laboratories (ABT) Stock Analysis — Probabli.AI
AI-powered analysis for ABT (Abbott Laboratories): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $87.48 · Market cap: $152.9B · AI consensus: Bullish
Abbott Laboratories is well-positioned for substantial growth, driven by its strong fundamentals, innovative product lineup, and consistent earnings performance. While legal and regulatory challenges present risks, the company's proactive strategies in healthcare innovation and strong analyst backing build overarching bullish sentiment.
Probabilistic 1-Year Outlook
- Bull 5500% · Neutral 3000% · Bear 1500%
- Abbott's consistent earnings beats and strong revenue growth projections position it favorably for a strong year ahead. However, legal challenges and minor clinical setbacks contribute to some downside risk.
5-Year Outlook
- Bull 6000% · Neutral 2500% · Bear 1500%
SWOT Highlights
- Strength: Strong earnings beat streak
- Strength: High analyst consensus with BUY rating
- Risk: High payout ratio limiting future flexibility
- Risk: Legal challenges including patent disputes
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
20 Wall Street analysts rate ABT a BUY with a mean price target of $130.9. Abbott Laboratories currently pays a dividend with a yield of approximately 2.88%.
Analysis generated May 22, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/ABT.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.